CA2623477C - Compositions and method for treating pediatric hypogonadism - Google Patents

Compositions and method for treating pediatric hypogonadism Download PDF

Info

Publication number
CA2623477C
CA2623477C CA2623477A CA2623477A CA2623477C CA 2623477 C CA2623477 C CA 2623477C CA 2623477 A CA2623477 A CA 2623477A CA 2623477 A CA2623477 A CA 2623477A CA 2623477 C CA2623477 C CA 2623477C
Authority
CA
Canada
Prior art keywords
testosterone
use according
age
treatment
boy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2623477A
Other languages
English (en)
French (fr)
Other versions
CA2623477A1 (en
Inventor
Robert E. Dudley
Alan Rogol
Janet Benesh
Troy L. Zumbrunnen
Gregg Pratt
John J. Brennan
Hjalmar Lagast
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Besins Healthcare Luxembourg SARL
Unimed Pharmaceuticals LLC
Original Assignee
Laboratoires Besins International SAS
Unimed Pharmaceuticals LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Besins International SAS, Unimed Pharmaceuticals LLC filed Critical Laboratoires Besins International SAS
Publication of CA2623477A1 publication Critical patent/CA2623477A1/en
Application granted granted Critical
Publication of CA2623477C publication Critical patent/CA2623477C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
CA2623477A 2007-03-23 2008-03-20 Compositions and method for treating pediatric hypogonadism Active CA2623477C (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US89655207P 2007-03-23 2007-03-23
EP07104726 2007-03-23
EP07104726.0 2007-03-23
US60/896,552 2007-03-23

Publications (2)

Publication Number Publication Date
CA2623477A1 CA2623477A1 (en) 2008-09-23
CA2623477C true CA2623477C (en) 2011-05-31

Family

ID=38321980

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2623477A Active CA2623477C (en) 2007-03-23 2008-03-20 Compositions and method for treating pediatric hypogonadism

Country Status (10)

Country Link
EP (1) EP2136813A2 (cg-RX-API-DMAC7.html)
JP (1) JP2010521519A (cg-RX-API-DMAC7.html)
CN (1) CN101754764A (cg-RX-API-DMAC7.html)
AU (1) AU2008231781B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0809124A8 (cg-RX-API-DMAC7.html)
CA (1) CA2623477C (cg-RX-API-DMAC7.html)
EA (1) EA018775B1 (cg-RX-API-DMAC7.html)
IL (1) IL200887A0 (cg-RX-API-DMAC7.html)
MX (1) MX2009008995A (cg-RX-API-DMAC7.html)
WO (1) WO2008116825A2 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO3755B1 (ar) * 2011-01-26 2021-01-31 Ferring Bv تركيبات تستوستيرون
MX2013013369A (es) * 2011-05-15 2014-10-17 Trimel Biopharma Srl Formulaciones de gel bioadhesivo de testosterona intranasal y uso del mismo para tratar hipogonadismo masculino.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6503894B1 (en) * 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
US20030139384A1 (en) * 2000-08-30 2003-07-24 Dudley Robert E. Method for treating erectile dysfunction and increasing libido in men
US20040072810A1 (en) * 2001-11-07 2004-04-15 Besins International Belgique Pharmaceutical composition in the form of a gel or a solution based on dihydrotestosterone, process for preparing it and uses thereof
US7138389B2 (en) * 2004-02-09 2006-11-21 University Of Washington Oral androgen therapy using modulators of testosterone bioavailability
RS52671B (sr) * 2005-10-12 2013-06-28 Unimed Pharmaceuticals Llc Poboljšani gel testosterona i postupak korišćenja

Also Published As

Publication number Publication date
BRPI0809124A8 (pt) 2015-11-24
EA200901288A1 (ru) 2010-04-30
MX2009008995A (es) 2009-09-03
AU2008231781A1 (en) 2008-10-02
EA018775B1 (ru) 2013-10-30
EP2136813A2 (en) 2009-12-30
WO2008116825A3 (en) 2008-11-27
IL200887A0 (en) 2010-05-17
AU2008231781B2 (en) 2012-09-20
WO2008116825A2 (en) 2008-10-02
JP2010521519A (ja) 2010-06-24
CA2623477A1 (en) 2008-09-23
BRPI0809124A2 (pt) 2014-08-26
CN101754764A (zh) 2010-06-23

Similar Documents

Publication Publication Date Title
US20080261937A1 (en) Pharmaceutical compositions and method for treating pediatric hypogonadism
EP1322336B1 (en) Method of increasing testosterone and related steroid concentrations in women
US20120245134A1 (en) Androgen pharmaceutical composition and method for treating depression
US20050049233A1 (en) Method for treating erectile dysfunction and increasing libido in men
US20090318398A1 (en) Androgen pharmaceutical composition and method for treating depression
EP2283865A1 (en) Method of increasing testosterone and related steroid concentrations in women
JP2005515964A (ja) ホルモン欠乏症を治療するための治療用組成物
EP3456329B1 (en) Improved testosterone gel and method of use
IL186356A (en) Transdermal hydraulic alcohol gel preparation for use in the treatment of type 2 diabetes
EP1511494B1 (en) Androgen pharmaceutical composition and method for treating depression
AU2008231781B2 (en) Compositions and method for treating pediatric hypogonadism

Legal Events

Date Code Title Description
EEER Examination request
MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 17TH ANNIV.) - STANDARD

Year of fee payment: 17

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20241210

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT

Effective date: 20241210

MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 18TH ANNIV.) - STANDARD

Year of fee payment: 18

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20250304

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT

Effective date: 20250304